
    
      An Open Label, Randomized, 2-period, 2- Treatment, 2-Sequence, Crossover, Single-dose
      Bioequivalence Study of FDC of Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide
      Tablets 40+10+25 mg containing Olmesartan medoxomil 40 mg, Amlodipine 10 mg and
      Hydrochlorothiazide 25 mg ( Test Formulation, Torrent Pharmaceutical Ltd., India) Versus
      TribenzorÂ® 40+10+25 mg Tablets containing Olmesartan medoxomil 40 mg, Amlodipine 10 mg and
      Hydrochlorothiazide 25 mg (Reference , Daichi Sankyo Inc, USA.) in Healthy Human Volunteers
      Under Fasting Condition.
    
  